Recording intelligenceAI-generated brief · check the source for context

Twiv Episode 1303

1:50:31 recording · AUTO · 4 speakers

Listen to the original

Listen to the episode
Executive Summary AI
  • This Week in Virology episode 1303, recorded on March 6, 2026, has Vincent Racaniello hosting Alan Dove, Brianne Barker and Rich Condit, with weather, a Rosenfeld Lab job notice and Alan's report on Tony Hunter's Janssen Award and an 86-year-old Harold Varmus.0:10
  • The first paper, by Jung Ki Kim and Eileen Crimmins at the University of Southern California in the Journal of Gerontology, used 3,884 Health and Retirement Study adults of mean age about 78, roughly half of them shingles-vaccinated, with blood taken in the 2016 Venous Blood Study.22:47
  • After adjusting for demographic, socioeconomic and health covariates, vaccination was tied to more favorable inflammation, epigenetic and transcriptomic aging and a lower composite aging score, while the adaptive immunity score rose, which in their scoring means poorer function, and the effects persisted beyond four years.27:54
  • The main paper, first author Haibo Zhang and senior author Bali Pulendran in Science, gave mice four intranasal doses of the TLR4 agonist GLA plus the TLR7-8 agonist 3M-052 with ovalbumin, and the mice lost less weight and carried less virus when challenged at 21 days, 42 days and three months with SARS-CoV-2, and were also protected against SARS-CoV, SHC014, Staph aureus and Acinetobacter baumann57:29
  • Depleting CD4 and CD8 T cells lowered CD86 and MHC on alveolar macrophages and abolished protection, as did blocking RANKL, pointing to a feed-forward circuit in which T cells talk back to the macrophages; Brianne, Rich and Alan closed with picks on vaccine hesitancy, the London bus study and the book Waste Wars.1:15:36

Brief overview

Two vaccine papers suggest shingles vaccination slows biological aging and mucosal TLR vaccines broadly protect mice.

  1. Shingles vaccination tracks with slower biological agingIn the 3,884-person cohort, vaccinated adults showed lower inflammation, epigenetic and transcriptomic aging scores after adjustment.
  2. An intranasal TLR vaccine protected mice broadlyGLA plus 3M-052 with ovalbumin reduced viral and bacterial loads with no pathogen antigen in the vaccine.
  3. T cells train the alveolar macrophagesDepleting T cells or blocking RANKL removed the macrophage activation and the protection entirely.

Questions this recording answers

10 questions, each answered where it is said
Does the shingles vaccine actually slow biological aging?

Kim and Crimmins report that shingles vaccination is associated with initial reductions in epigenetic and transcriptomic aging and in the composite biological aging score, with the effect persisting over time, seemingly more than four years. Vincent says the vaccine seems to slow aging, but stresses this is an observational study needing longitudinal work.

Answered around 31:29
Which biological domains improved in the vaccinated people?

After linear regression adjusting for demographic, socioeconomic and health-related covariates, vaccination is associated with more favorable profiles in inflammation, epigenetic aging and transcriptomic aging. Lower inflammation scores suggest reduced chronic inflammation. Cardiovascular hemodynamics and neurodegeneration were not affected, and the adaptive immunity score moved the wrong way.

Answered around 27:54
How was the shingles vaccine and aging study designed?

They used the Health and Retirement Study cohort plus its 2016 Venous Blood Study: 3,884 older adults, mean age about 78, roughly half shingles-vaccinated. Covariates included age, sex, ethnicity, education years, household income, pack-years of smoking and doctor-diagnosed chronic conditions such as diabetes, cancer, heart disease and arthritis.

Answered around 22:47
Why did adaptive immunity look worse in the vaccinated group?

Shingles vaccination was associated with higher adaptive immunity scores, which in the authors' scoring system reflects poorer adaptive immune function. They suggest vaccination induces memory phenotypes, one of the features of immunosenescence, but say they really do not know why. Brianne notes inflammation and adaptive immunity are probably tied together.

Answered around 29:52
What is the difference between Zostavax and Shingrix?

Zostavax is the live attenuated varicella zoster vaccine, given to people over 60 at 14 times the children's dose. Shingrix, from 2016, is a subunit vaccine, just a protein with no virus in it at all, and is much more effective against shingles in adults. It is not yet used in children.

Answered around 14:46
Did the mouse nasal vaccine protect against pathogens it did not contain?

Mice given four intranasal doses were challenged at 21 days, 42 days and three months with SARS-CoV-2, and showed less weight loss, lower viral genome loads, and less inflammation and alveolar damage. Protection also covered original SARS-CoV, the bat coronavirus SHC014, Staph aureus and Acinetobacter baumannii, with no coronavirus antigen used.

Answered around 57:29
What was actually in the intranasal vaccine given to the mice?

A toll-like receptor agonist mixture given intranasally: GLA, which hits TLR4, plus 3M-052-LS for TLR7-8, which Brianne shortened to GLAM, combined with ovalbumin as the antigen. The authors picked them for favorable safety records and complementary MyD88-dependent pathways; both have been studied in non-human primates and entered clinical evaluation.

Answered around 56:36
Are T cells needed for that broad protection to work?

Yes. Depleting CD4 and CD8 T cells removed vaccine-mediated protection against both SARS-CoV-2 and Staph aureus, and CD86 and MHC upregulation on alveolar macrophages dropped. The T cell talks back to the macrophage and improves it, a feed-forward circuit, which is how protection reaches antigens the vaccine never contained.

Answered around 1:12:20
Did the nasal vaccine do anything for allergic airway disease?

They vaccinated mice in a house dust mite model and found reduced infiltration of eosinophils and other markers associated with type 2 hypersensitivity, and depleting T cells abrogated that protective effect. So the same regimen protected against respiratory pathogens and dust mite induced asthma, which the authors describe as mitigating allergic inflammation.

Answered around 1:23:49
Does the ICTV decide what a virus is commonly called?

No. Siddell and Smith write that the ICTV is the body formally responsible for virus taxonomy, but common names are chosen by the virologists who study them, and there is no such thing as an official virus name. Common names such as poliovirus or cafeteria roenbergensis virus are therefore not italicized.

Answered around 42:24
Key Quote

“He is exactly as sharp, maybe even a little sharper than he was on TWIV 400.”

— Alan Dove, Twiv Episode 1303, at 7:28▶ listen at 7:28
Key Quote

“The vaccine seems to slow aging.”

— Vincent Racaniello, Twiv Episode 1303, at 31:42▶ listen at 31:42
Key Quote

“But what this seems to imply is that the T cell is going to talk back to the macrophage.”

— Brianne Barker, Twiv Episode 1303, at 1:14:31▶ listen at 1:14:31
Key Quote

“So to be clear, metal and paper are great for recycling.”

— Alan Dove, Twiv Episode 1303, at 1:38:54▶ listen at 1:38:54

Cite this

“Twiv Episode 1303.” https://traffic.libsyn.com/secure/twiv/TWiV1303.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/twiv-episode-1303.html.

Report this page
What is wrong with this page?